Skip to main content
. 2022 Apr 28;44(3):1551–1562. doi: 10.1007/s11357-022-00576-6

Table 2.

OCT-A parameters in control participants and PD patients with different Hoehn-Yahr stages

Control participants (n = 45) PD patients P value#
Stage I (n = 20) Stage II + III (n = 22)
Age, years (mean ± SD) 64.33 ± 11.78 64.20 ± 6.05 66.41 ± 7.00 0.29
Sex, male, n (%) 11 (24.4) 8 (40.0) 12 (54.5) 0.35
FAZ (mm2) 0.28 ± 0.10 0.28 ± 0.09 0.27 ± 0.10 0.77
VDsM, fovea (%) 18.11 ± 6.95 17.85 ± 6.81 18.37 ± 7.07 0.50
VDsM, parafovea (%) 46.77 ± 5.19 46.92 ± 5.65 46.64 ± 4.71 0.50
VDdM, fovea (%) 32.66 ± 6.39 32.12 ± 6.00 33.17 ± 6.70 0.34
VDdM, parafovea (%) 51.63 ± 5.36 52.83 ± 4.95 50.50 ± 5.49 0.04*
VDrID (%) 50.65 ± 6.83 52.50 ± 6.70 48.91 ± 6.49 0.03*
VDrPP (%) 49.36 ± 6.52 48.19 ± 8.78 50.47 ± 2.69 0.26

Data are expressed as means ± standard deviation

OCT-A, optical coherence tomography angiography; FAZ, foveal avascular zone; VDsM, vessel density in the superficial plexus of the central macula; VDdM, vessel density in the deep plexus of the central macula; VDrID, vessel density in the radial peripapillary capillary layer of the disc region; VDrPP, vessel density in the radial peripapillary capillary layer of the peripapillary region

#Comparison between PD patients with Hoehn-Yahr stage I and those with Hoehn-Yahr stage II and III. *P < 0.05